Dear Editor, We report an unusual cause of hyperammonemia in a critically ill patient undergoing chemotherapy. A 62-year-old woman was admitted to our Intensive Care Unit (ICU) for respiratory failure and septic shock. She was diagnosed as having a disseminated T cell lymphoma complicating a chronic infection with Epstein-Barr virus. On admission, she was treated with mechanical ventilation and norepinephrine; bronchoalveolar lavage yielded wildtype Klebsiella pneumoniae for which piperacillin/tazobactam was administered intravenously. Her clinical condition improved rapidly, but the total body computed tomography (CT) scan showed disseminated lymphomatous lesions in the lungs and the liver. Chemotherapy, consisting of cyclophosphamide, hydroxydaunorubicin, vincristine and prednisolone, was started on day 7 after admission. Bilirubin levels at this time were greater than 8 mg/dl, and blood ammonia (NH 4 ) levels were 80 lg/dl (Fig. 1) . Unfortunately, there was no response to the initial chemotherapy, so a secondline chemotherapy was initiated consisting of prednisolone, methotrexate, ifosfamide, etoposide and L-asparaginase. After the first administration of L-asparaginase, NH 4 levels increased to 399 lg/dl, with no other alteration in liver function tests and no neurological signs or symptoms. Oral lactulose (30 g q8h) was started. NH 4 levels increased again with the two subsequent L-asparaginase injections (Fig. 1) . On day 26 (at the time of the last drug injection), serial NH 4 levels were 233 lg/dl before drug injection, 262 lg/dl at 1 h, 249 lg/dl at 4 h and 521 lg/dl at 8 h after asparaginase; levels progressively decreased to 381 lg/dl the day after the injection and to less than 100 lg/dl 48 h thereafter. No specific neurological deterioration was observed at any time.
Hyperammonemia can occur in critically ill patients, especially in those suffering from decompensated liver cirrhosis, acute liver failure or receiving certain drugs, such as valproic acid [1] . If untreated, elevated NH 4 levels may progressively cause brain edema and subsequent herniation. L-Asparaginase hydrolyzes the amino acid, asparagine, thus depriving cancer cells of an essential compound for growth but also producing ammonia [2] . This patient had hepatic involvement from T cell lymphoma and had a mild, asymptomatic increase in NH 4 levels during the first day after ICU admission. Her underlying septic shock may have been a predisposing factor for the development of severe hyperammonemia during L-asparaginase therapy. Several case reports have described the development of hyperammonemia during L-asparaginase therapy, notably in children or young patients undergoing chemotherapy for hematological diseases [2] [3] [4] . Our patient had no neurological abnormalities, whereas in previous reports, most of the patients had a poor outcome with clinical signs of brain edema. We observed that the peak in NH 4 concentrations was observed a few hours after drug injection, and levels returned to baseline within 48 h without further therapy. In one report, clinical signs of brain edema appeared less than 2 h after drug administration, and the condition progressively deteriorated over subsequent days, necessitating administration of sodium benzoate [4] .
Although hyperammonemia is a rare complication of chemotherapy, it is likely to be seen more frequently as the numbers of patients suffering from cancer and receiving chemotherapy who are admitted to the ICU 
